Αρχική World News Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes... World News Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes in Pretreated Patients with Metastatic Cancer Από Ogkologos - 14 Οκτωβρίου, 2025 424 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROME study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Minimizing Time Between Diagnosis and End of Treatment Improves Breast Cancer... 5 Ιουλίου, 2021 The Frontline Oncology Workforce Unites to Reduce the Burden of Cancer... 9 Σεπτεμβρίου, 2022 Cancer clinical trials – learning lessons from the COVID-19 pandemic 19 Μαΐου, 2021 Larger NGS Gene Panel Linked to More Clinical Utility 16 Οκτωβρίου, 2020 Φόρτωση περισσοτέρων HOT NEWS COVID-19: “The really hard part is we know what needs to... Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies News digest – targeted ‘lava lamp’ treatment, skin cancer biopsies and... Speaking for Scotland: What our Scottish Campaigns Ambassadors want in a...